Literature DB >> 6619135

3-Mercaptopicolinate. A reversible active site inhibitor of avian liver phosphoenolpyruvate carboxykinase.

A L Makinen, T Nowak.   

Abstract

The inhibition of chicken liver phosphoenolpyruvate carboxykinase by 3-mercaptopicolinic acid (3-MP) has been investigated. Kinetic studies show 3-MP to be a noncompetitive inhibitor relative to all substrates and to the activator, Mn2+. EPR studies demonstrate that Mn2+ binding to the enzyme is unaffected by 3-MP. Proton relaxation rate studies demonstrate that 3-MP binds to the binary E X Mn complex with a KD of 0.5 X 10(-6) M and gives a ternary enhancement of 8.0. Additional proton relaxation rate studies detected formation of the quaternary complexes E X Mn X IDP X 3-MP, E X Mn X ITP X 3-MP, and E X Mn X CO2 X 3-MP. High resolution 1H nuclear relaxation rate studies suggest that 3-MP binds in close proximity to the activator cation, Mn2+, but not in the first coordination sphere. Active site models suggest that the 3-MP-binding site may partially overlap the phosphoenolpyruvate-binding site. The NMR studies, which detected formation of the quaternary E X Mn X 3-MP X phosphoenolpyruvate complex, also demonstrated that the binding of one of these ligands affects the interactions of the other ligand with E X Mn. Calorimetric studies of the E X Mn complex demonstrated that 3-MP causes an increase in the transition temperature midpoint without an increase in enthalpy. These results indicate that 3-MP causes a conformational change in the enzyme but does not increase the thermostability of the ternary complex. The experiments reported herein suggest that inhibition by 3-MP is due to specific and reversible binding within the active site of phosphoenolpyruvate carboxykinase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619135

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish.

Authors:  Agata Jurczyk; Nicole Roy; Rabia Bajwa; Philipp Gut; Kathryn Lipson; Chaoxing Yang; Laurence Covassin; Waldemar J Racki; Aldo A Rossini; Nancy Phillips; Didier Y R Stainier; Dale L Greiner; Michael A Brehm; Rita Bortell; Philip diIorio
Journal:  Gen Comp Endocrinol       Date:  2010-10-20       Impact factor: 2.822

2.  Glycogen synthesis in amphibian oocytes: evidence for an indirect pathway.

Authors:  E Kessi; V Guixé; A Preller; T Ureta
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

3.  PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.

Authors:  K Leithner; A Hrzenjak; M Trötzmüller; T Moustafa; H C Köfeler; C Wohlkoenig; E Stacher; J Lindenmann; A L Harris; A Olschewski; H Olschewski
Journal:  Oncogene       Date:  2014-03-17       Impact factor: 9.867

4.  Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome.

Authors:  Rajeswari Banerji; Christopher Huynh; Francisco Figueroa; Matthew T Dinday; Scott C Baraban; Manisha Patel
Journal:  Brain Commun       Date:  2021-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.